Current evidence for safety and efficacy of anti–programmed cell-death 1 agents in the treatment of cutaneous squamous cell carcinoma: A systematic review - 09/01/20
Doi : 10.1016/j.jaad.2019.09.044
Lauren M. Sadowsky, BA a, Cory Kosche, BS a, Dennis P. West, PhD a, b, Jennifer N. Choi, MD a, b, ⁎ 
a Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
b Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
∗Reprint requests: Jennifer N. Choi, MD, Northwestern University Feinberg School of Medicine, Department of Dermatology, 676 N St. Clair St, Ste 1600, Chicago, IL 60611Northwestern University Feinberg School of MedicineDepartment of Dermatology676 N St. Clair StSte 1600ChicagoIL60611
| Data from this study were presented as a poster and accompanying abstract at the American Academy of Dermatology Conference Poster Exhibit Program at the 2019 Annual Meeting, Washington, DC, March 1-5, 2019. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not required. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 2
P. 522-524 - février 2020 Retour au numéro
Article précédent
- Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)
- Mark G. Lebwohl, Craig L. Leonardi, Nehal N. Mehta, Alice B. Gottlieb, Alan M. Mendelsohn, Jeff Parno, Stephen J. Rozzo, Alan Menter
- Prescription-strength topical corticosteroids available over the counter: Cross-sectional study of 80 stores in 13 United States cities
- Rebecca S. Kimyon, Jamie P. Schlarbaum, Yujie Linda Liou, Brandon L. Adler, Alyssa Breneman, Jeanette R. Comstock, Chelsea Handfield, Dawson Kimyon, Hannah Kopelman, Ross Kopelman, Vidhi Patel, Jodie Raffi, Fernanda Salgado, Sara A. Hylwa, Erin M. Warshaw
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?